Patents by Inventor Anne Reilly

Anne Reilly has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7473467
    Abstract: The invention relates to a complex coacervation process based on the use of type B gelatin as polycationic colloid, for the preparation of “Halal” certified flavor-containing microcapsules.
    Type: Grant
    Filed: September 3, 2002
    Date of Patent: January 6, 2009
    Assignee: Firmenich SA
    Inventors: Anandaraman Subramaniam, Anne Reilly
  • Publication number: 20050123757
    Abstract: The invention relates to a process for preparing microcapsules by coacervation, wherein the cross-linking of a protein is carried out by a plant extract rich in substituted or unsubstituted phenolic compounds.
    Type: Application
    Filed: January 18, 2005
    Publication date: June 9, 2005
    Inventors: Anandaraman Subramaniam, Anne Reilly
  • Publication number: 20040041306
    Abstract: The invention relates to a complex coacervation process based on the use of type B gelatin as polycationic colloid, for the preparation of “Halal” certified flavor-containing microcapsules.
    Type: Application
    Filed: September 3, 2002
    Publication date: March 4, 2004
    Inventors: Anandaraman Subramaniam, Anne Reilly
  • Publication number: 20040032036
    Abstract: The invention relates to a process for preparing microcapsules by coacervation, wherein the cross-linking of a protein is carried out by a plant extract rich in substituted or unsubstituted phenolic compounds.
    Type: Application
    Filed: August 19, 2002
    Publication date: February 19, 2004
    Inventors: Anandaraman Subramaniam, Anne Reilly
  • Patent number: 5965124
    Abstract: Replication-competent recombinant viruses, particularly replication-competent recombinant polioviruses, which include (1) exogenous nucleic acid sequences which encode an exogenous polypeptide and (2) a nucleic acid sequence which encodes an artificial proteolytic cleavage site for a viral or cellular protease which proteolytically processes (cleaves) the precursor protein produced by the parent virus and uses therefor. The recombinant precursor is cleaved into the usual array of constituent proteins, freeing the exogenous polypeptide. Replication-competent recombinant viruses are useful as vaccines against bacterial, viral, fungal and yeast infections, parasitic diseases, cancer and allergies.
    Type: Grant
    Filed: January 31, 1995
    Date of Patent: October 12, 1999
    Assignees: Whitehead Institute for Biomedical Research, American Cynamid Company
    Inventors: Mark Feinberg, Raul Andino, Carolyn Louise Weeks-Levy, Patricia Anne Reilly